Jason Hampson
Consigliere Generale presso KINNATE BIOPHARMA INC.
Profilo
Jason Hampson is currently the Vice President & Head-Regulatory Affairs at Kinnate Biopharma, Inc. He previously worked as the Director-Regulatory Affairs at Amgen, Inc. Hampson completed his undergraduate degree at the University of the West of England.
Posizioni attive di Jason Hampson
| Società | Posizione | Inizio |
|---|---|---|
| KINNATE BIOPHARMA INC. | Consigliere Generale | 07/06/2021 |
Precedenti posizioni note di Jason Hampson
| Società | Posizione | Fine |
|---|---|---|
| AMGEN INC. | Consigliere Generale | 01/05/2021 |
Formazione di Jason Hampson
| University of the West of England | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| AMGEN INC. | Health Technology |
| Aziende private | 1 |
|---|---|
Kinnate Biopharma, Inc.
 Kinnate Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Kinnate Biopharma, Inc. operates as a biopharmaceutical company engaged in the research and development of Kinnate Discovery Engine that targets genomic drivers of cancer. The company was founded by Stephen W. Kaldor and Eric A. Murphy in January 2018 and is headquartered in San Diego, CA. | Health Technology |
- Borsa valori
- Insiders
- Jason Hampson
